© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Karuna Therapeutics, Inc. (KRTX) shows an Average True Range (ATR) of 3.32 and an Enterprise Value of 12.43B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into KRTX's underlying financial health and market activity.
| ATR | 3.32 |
| Enterprise Value | 12.43B |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Karuna Therapeutics, Inc. (KRTX) technical indicators as of February 6, 2026: the SMA 20 is 3.27%, SMA 50 at 3.92%, and SMA 200 at 44.47%. The RSI 14 value is 75.4, suggesting its current momentum. These technical analysis signals help assess KRTX's price trends and potential future movements.
| SMA 20 | 3.27% |
| SMA 50 | 3.92% |
| SMA 200 | 44.47% |
| RSI 14 | 75.4 |
Karuna Therapeutics, Inc. (KRTX) stock performance overview as of February 6, 2026: The 52-week high is N/A (currently -0.05% below), and the 52-week low is N/A (currently 108.26% above). Over the past year, KRTX's performance is 64.51%, compared to the S&P 500's 8.96% change.
| 52-Week High | N/A |
| 52-Week High Chg | -0.05% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +108.26% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Karuna Therapeutics, Inc. (KRTX) stock's recent performance metrics show that over the last month, KRTX is 0.83%, with a Year-to-Date (YTD) performance of 0.91%. Over the past year, the stock has seen a 64.51% change. These figures summarize KRTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | +1.03% | +0.83% | +85.95% | +77.94% | +64.51% | +0.91% |
According to current financial data, KRTX stock's P/E (TTM) ratio is -28.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for KRTX, including P/S (19264.95), P/B (9.72), and P/FCF (-32.41), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KRTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -28.11 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 19264.95 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 9.72 | N/A | 8.93 | 5.45 |
| P/FCF (TTM) | -32.41 | -5.21 | -192.01 | 31.94 |